Merit Medical Systems Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, Merit Medical Systems stock has a consensus rating of "Buy" and an average price target of $90.09. The average 1-year stock price forecast is 21.13% higher than the current stock price, while the lowest is $74 (-0.50%) and the highest is $110 (+47.90%).

Price Target: $90.09 (+21.13%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$74	$90.09	$89	$110
Change	-0.50%	+21.13%	+19.66%	+47.90%

Analyst Ratings

The average analyst rating for Merit Medical Systems stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Feb '26	Mar '26	Apr '26	May '26	Jun '26	Jul '26
Strong Buy	4	4	4	4	4	4
Buy	5	5	5	5	5	5
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	11	11	11	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Petusky Barrington	Barrington	Buy Reiterates $107	Buy	Reiterates	$107	+43.87%	Jul 14, 2026
Jason Bednar Piper Sandler	Piper Sandler	Buy Reiterates $96	Buy	Reiterates	$96	+29.08%	Jul 10, 2026
David Rescott Robert W. Baird	Robert W. Baird	Buy Maintains $92 → $83	Buy	Maintains	$92 → $83	+11.60%	May 1, 2026
Robbie Marcus J.P. Morgan	J.P. Morgan	Buy Maintains $95 → $77	Buy	Maintains	$95 → $77	+3.53%	May 1, 2026
Jayson Bedford Raymond James	Raymond James	Buy Maintains $101 → $83	Buy	Maintains	$101 → $83	+11.60%	May 1, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.62B

from 1.52B

6.86%

from 1.52B

Revenue Next Year

1.72B

from 1.62B

6.06%

from 1.62B

EPS This Year

4.07

from 3.83

6.35%

from 3.83

EPS Next Year

4.40

from 4.07

8.03%

from 4.07

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.07B	1.15B	1.26B	1.36B	1.52B	1.62B
Revenue Growth	11.50%	7.09%	9.24%	7.89%	11.75%	6.86%
Gross Profit	485.33M	519.10M	583.87M	643.33M	738.27M	871.50M
Gross Margin	45.16%	45.10%	46.44%	47.43%	48.70%	53.80%
Operating Income	84.40M	108.26M	135.07M	168.04M	193.90M	335.32M
Net Income	48.45M	74.52M	94.41M	120.36M	128.49M	160.48M
EPS	-	-	-	-	3.83	4.07
EPS Growth	-	-	-	-	10.69%	6.35%
Forward PE	27.70	25.97	24.04	27.13	22.51	18.26
Free Cash Flow	142.07M	51.35M	106.20M	184.91M	179.71M	218.96M
No. Analysts	-	-	-	-	-	10

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	1.6B
Avg	1.6B
Low	1.6B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	7.4%
Avg	6.9%
Low	6.1%

EPS Forecast

Chart

EPS	2026	2027	2028
High	4.13
Avg	4.07
Low	4.03

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	7.8%
Avg	6.4%
Low	5.2%